LAC DPH Health Update: Revisions to Evusheld Dosing February 28, 2022 Key Messages The FDA has revised the emergency use authorization for Evusheld (tixagevimab plus cilgavimab) to increase the dose (from ... Read More
CAHAN Health Update: Distribution and Patient Prioritization for Tixagevimab/Cilgavimab (Evusheld) February 18, 2022 The California Department of Public Health (CDPH) issued a CAHAN on the distribution and patient prioritization for tixagevimab/cilgavimab (Evusheld). Evusheld ... Read More